SC orders panel to curb unethical pharma marketing

The Supreme Court directed the Centre to form an expert committee recommending a statutory mechanism to regulate pharmaceutical marketing practices. The order follows a petition by FMRAI highlighting gifts, foreign trips, and freebies used to influence doctors. The existing voluntary UCPMP framework was deemed insufficient. A compliance report is due January 29, 2027.